Literature DB >> 15180958

Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand.

Daniel E Bauer1, Marian H Harris, David R Plas, Julian J Lum, Peter S Hammerman, Jeffrey C Rathmell, James L Riley, Craig B Thompson.   

Abstract

The relationship between growth factor-dependent cell growth and proliferation and the up-regulation of cellular metabolism required to support these processes remains poorly defined. Here, we demonstrate that cell growth, proliferation, and glucose metabolism are coordinately regulated by interleukin-3 (IL-3) in cytokine-dependent cells. Surprisingly, glycolytic activity is stimulated to a greater extent than would be expected based on the rate of cell growth or proliferation. IL-3 signaling exerts a direct effect on glycolytic commitment independent of cell growth control. These results are not restricted to IL-3 as the cytokines IL-7 and IL-2 have similar effects on glucose metabolism when assayed in factor-dependent cell lines or primary lymphocytes, respectively. Growth factor stimulation leads cells to consume less oxygen and produce more lactate per glucose, indicative of conversion from oxidative to glycolytic metabolism. The enforced rate of glucose metabolism is in excess of that required to support cell growth; accordingly, if extracellular glucose is reduced, cells retain the ability to grow and proliferate by derepressing oxidative metabolism. These data suggest that the high rate of glycolysis observed in response to growth factor stimulation is a primary effect rather than a homeostatic response to increased cell growth.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15180958      PMCID: PMC4458073          DOI: 10.1096/fj.03-1001fje

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  38 in total

1.  Overexpression of UCP3 in cultured human muscle lowers mitochondrial membrane potential, raises ATP/ADP ratio, and favors fatty acid vs. glucose oxidation.

Authors:  C García-Martinez; B Sibille; G Solanes; C Darimont; K Macé; F Villarroya; A M Gómez-Foix
Journal:  FASEB J       Date:  2001-07-24       Impact factor: 5.191

Review 2.  Signaling by type I and II cytokine receptors: ten years after.

Authors:  M Gadina; D Hilton; J A Johnston; A Morinobu; A Lighvani; Y J Zhou; R Visconti; J J O'Shea
Journal:  Curr Opin Immunol       Date:  2001-06       Impact factor: 7.486

3.  Akt and Bcl-xL promote growth factor-independent survival through distinct effects on mitochondrial physiology.

Authors:  D R Plas; S Talapatra; A L Edinger; J C Rathmell; C B Thompson
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

4.  Observations on the proliferation of human leucocytes cultured with phytohaemagglutinin.

Authors:  E H COOPER; P BARKHAN; A J HALE
Journal:  Br J Haematol       Date:  1963-01       Impact factor: 6.998

5.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

6.  Changes in the carbohydrate metabolism of mitogenically stimulated human peripheral lymphocytes. I. Stimulation by phytohaemagglutinin.

Authors:  D Roos; J A Loos
Journal:  Biochim Biophys Acta       Date:  1970-12-29

7.  Phytohaemagglutinin stimulation of rat thymus lymphocytes glycolysis.

Authors:  J G Culvenor; M J Weidemann
Journal:  Biochim Biophys Acta       Date:  1976-07-21

8.  Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway.

Authors:  H E Fleming; C J Paige
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

9.  Site-specific serine phosphorylation of the IL-3 receptor is required for hemopoietic cell survival.

Authors:  M A Guthridge; F C Stomski; E F Barry; W Winnall; J M Woodcock; B J McClure; M Dottore; M C Berndt; A F Lopez
Journal:  Mol Cell       Date:  2000-07       Impact factor: 17.970

10.  Early effects of phytohaemagglutinin on glucose metabolism of normal human lymphocytes.

Authors:  C J Hedeskov
Journal:  Biochem J       Date:  1968-11       Impact factor: 3.857

View more
  78 in total

Review 1.  Staying alive: metabolic adaptations to quiescence.

Authors:  James R Valcourt; Johanna M S Lemons; Erin M Haley; Mina Kojima; Olukunle O Demuren; Hilary A Coller
Journal:  Cell Cycle       Date:  2012-05-01       Impact factor: 4.534

2.  Signaling in control of cell growth and metabolism.

Authors:  Patrick S Ward; Craig B Thompson
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-07-01       Impact factor: 10.005

3.  Changing the energy of an immune response.

Authors:  Meghan M Delmastro-Greenwood; Jon D Piganelli
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

4.  Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics.

Authors:  Patrick-Denis St-Coeur; Julie J Poitras; Miroslava Cuperlovic-Culf; Mohamed Touaibia; Pier Morin
Journal:  J Neurooncol       Date:  2015-08-28       Impact factor: 4.130

5.  Mitochondrial translocation of signal transducer and activator of transcription 5 (STAT5) in leukemic T cells and cytokine-stimulated cells.

Authors:  Fu-Yu Chueh; King-Fu Leong; Chao-Lan Yu
Journal:  Biochem Biophys Res Commun       Date:  2010-10-29       Impact factor: 3.575

Review 6.  Brick by brick: metabolism and tumor cell growth.

Authors:  Ralph J Deberardinis; Nabil Sayed; Dara Ditsworth; Craig B Thompson
Journal:  Curr Opin Genet Dev       Date:  2008-04-02       Impact factor: 5.578

7.  Proteomic and Metabolomic Characterization of a Mammalian Cellular Transition from Quiescence to Proliferation.

Authors:  Ho-Joon Lee; Mark P Jedrychowski; Arunachalam Vinayagam; Ning Wu; Ng Shyh-Chang; Yanhui Hu; Chua Min-Wen; Jodene K Moore; John M Asara; Costas A Lyssiotis; Norbert Perrimon; Steven P Gygi; Lewis C Cantley; Marc W Kirschner
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

8.  Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.

Authors:  Seong M Kim; Saurabh G Roy; Bin Chen; Tiffany M Nguyen; Ryan J McMonigle; Alison N McCracken; Yanling Zhang; Satoshi Kofuji; Jue Hou; Elizabeth Selwan; Brendan T Finicle; Tricia T Nguyen; Archna Ravi; Manuel U Ramirez; Tim Wiher; Garret G Guenther; Mari Kono; Atsuo T Sasaki; Lois S Weisman; Eric O Potma; Bruce J Tromberg; Robert A Edwards; Stephen Hanessian; Aimee L Edinger
Journal:  J Clin Invest       Date:  2016-09-26       Impact factor: 14.808

9.  Ceramide starves cells to death by downregulating nutrient transporter proteins.

Authors:  Garret G Guenther; Eigen R Peralta; Kimberly Romero Rosales; Susan Y Wong; Leah J Siskind; Aimee L Edinger
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-03       Impact factor: 11.205

Review 10.  Stalling the engine of resistance: targeting cancer metabolism to overcome therapeutic resistance.

Authors:  Ethan B Butler; Yuhua Zhao; Cristina Muñoz-Pinedo; Jianrong Lu; Ming Tan
Journal:  Cancer Res       Date:  2013-04-22       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.